BACKGROUND AND PURPOSE MR imaging, PET, and ictal SPECT have been studied extensively as individual techniques in the localization of epileptogenic foci, but only a few comparative studies have been done. We evaluated the concordance rates of ictal video/EEG, MR imaging, PET, and ictal SPECT to compare the sensitivities of these imaging methods in the lateralization of epileptogenic foci. MET...

gliomas account for almost 80% of primary malignant brain tumors in adults. magnetic resonance imaging (mri) is still the gold standard for diagnosis of brain tumors and brain 99mtc-tetrofosmin single photon emission computed tomography (99mtc-tetrofosmin-spect) has been established as a useful tool for their evaluation. fluorine-18–2-fluoro-2-deoxy-d-glucose positron emission tomography/comput...

Whole-body combined PET/MR imaging has found its way into clinical practice recently and has opened up new possibilities for multiparametric morphologic and functional imaging [1]. The first PET/MR studies identified clinical applications where PET/MRI as a combined modality may have advantages over the established modalities of PET/ CT and MRI, e. g., CNS imaging [2], local prostate imaging [3...

Positron emission tomography (PET) is well established as an important research and clinical molecular imaging modality. Although the size differences between humans and rodents create formidable challenges for the application of PET imaging in small animals, advances in technology over the past several years have enabled the translation of this imaging modality to preclinical applications. In ...

A clinical prototype of combined Combined Positron Emission Tomography (PET) / Computed Tomography (CT) system went under the clinical evaluation in 1998. After three years of research and clinical evaluation first clinical combined PET/CT system was installed in a clinic in 2001 [1-3]. Gradually clinical utilization of combined PET/CT increased tremendously particularly in oncological imaging ...

Introduction: Non Hodgkin Lymphoma (NHL) is a common hematologic malignancy accounting for 4% all cancers in United States. It is estimated that nearly 70,000 patients will be diagnosed with NHL in 2013, and 19,000 will die from this disease. 18-F FDG PET combined with anatomic CT imaging has been shown to be superior to contrast enhanced CT examination in staging of lymphoma. Thus PET/CT is ro...

Positron emission tomography (PET)/computed tomography (CT) imaging is frequently requested in Oncology. Radiologists and nuclear medicine physicians are often asked to perform a panel of imaging examinations as part of the initial staging or follow-up of cancer patients. Medical imaging must therefore integrate polyvalent skills enabling imaging specialists to understand and interpret all type...

Modern radiation therapy (RT) treatment planning is based on multimodality imaging. With the recent availability of whole-body PET/MR hybrid imaging new opportunities arise to improve target volume delineation in RT treatment planning. This, however, requires dedicated RT equipment for reproducible patient positioning on the PET/MR system, which has to be compatible with MR and PET imaging. A p...

Simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) is a new whole-body hybrid PET/MR imaging technique that combines metabolic and cross-sectional diagnostic imaging. Since the use of MRI in imaging of soft-tissue sarcoma is extremely beneficial, investigation of the combined PET/MRI is of great interest. In this paper, we present three cases and first data. Co...

Objective(s): The aim of this study was to analyze detection rates and effectiveness of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program for prostate cancer in Japan, which is defined as a cancer-screening program for subjects without known cancer. It contains FDG-PET aimed at detection of cancer at an early stage with or without additional screening tests ...